211 related articles for article (PubMed ID: 33507925)
1. The prognostic impact of lymphocyte-to-C-reactive protein score in patients undergoing surgical resection for intrahepatic cholangiocarcinoma: A comparative study of major representative inflammatory / immunonutritional markers.
Noguchi D; Kuriyama N; Nakagawa Y; Maeda K; Shinkai T; Gyoten K; Hayasaki A; Fujii T; Iizawa Y; Tanemura A; Murata Y; Kishiwada M; Sakurai H; Mizuno S
PLoS One; 2021; 16(1):e0245946. PubMed ID: 33507925
[TBL] [Abstract][Full Text] [Related]
2. High C-reactive protein/albumin ratio associated with reduced survival due to advanced stage of intrahepatic cholangiocarcinoma.
Kano H; Midorikawa Y; Song P; Nakayama H; Moriguchi M; Higaki T; Tsuji S; Takayama T
Biosci Trends; 2020 Sep; 14(4):304-309. PubMed ID: 32507777
[TBL] [Abstract][Full Text] [Related]
3. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels.
Lin ZY; Liang ZX; Zhuang PL; Chen JW; Cao Y; Yan LX; Yun JP; Xie D; Cai MY
BMC Cancer; 2016 Oct; 16(1):792. PubMed ID: 27733196
[TBL] [Abstract][Full Text] [Related]
4. The clinical significance of preoperative C-reactive protein/albumin ratio in patients with resected extrahepatic bile duct cancer.
Song DH; Cho IK; Shin DW; Lee JC; Cho JY; Yoon YS; Hwang JH; Han HS; Kim J
Surg Today; 2021 Jun; 51(6):978-985. PubMed ID: 33387024
[TBL] [Abstract][Full Text] [Related]
5. Impact of the Preoperative C-reactive Protein to Albumin Ratio on the Long-Term Outcomes of Hepatic Resection for Intrahepatic Cholangiocarcinoma.
Ito T; Shinkawa H; Takemura S; Tanaka S; Nishioka T; Miyazaki T; Ishihara A; Kubo S
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2373-2379. PubMed ID: 32856868
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma.
Gerhardt T; Milz S; Schepke M; Feldmann G; Wolff M; Sauerbruch T; Dumoulin FL
World J Gastroenterol; 2006 Sep; 12(34):5495-500. PubMed ID: 17006987
[TBL] [Abstract][Full Text] [Related]
7. Preoperative lymphocyte/C-reactive protein ratio and its correlation with CD8
Miyazaki K; Morine Y; Imura S; Ikemoto T; Saito Y; Yamada S; Tokuda K; Okikawa S; Yamashita S; Oya T; Tsuneyama K; Shimada M
Surg Today; 2021 Dec; 51(12):1985-1995. PubMed ID: 34009433
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma.
Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
J Gastroenterol; 2016 Feb; 51(2):153-61. PubMed ID: 26187429
[TBL] [Abstract][Full Text] [Related]
9. Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.
Wang JJ; Li H; Li JX; Xu L; Wu H; Zeng Y
World J Gastroenterol; 2020 Apr; 26(13):1501-1512. PubMed ID: 32308350
[TBL] [Abstract][Full Text] [Related]
10. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma.
Saito H; Noji T; Okamura K; Tsuchikawa T; Shichinohe T; Hirano S
Surgery; 2016 Mar; 159(3):842-51. PubMed ID: 26683498
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
[TBL] [Abstract][Full Text] [Related]
12. Association of Preoperative Platelet-to-Lymphocyte Ratio with Poor Outcome in Patients with Distal Cholangiocarcinoma.
Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Ogata Y
Oncology; 2019; 96(6):290-298. PubMed ID: 30909286
[TBL] [Abstract][Full Text] [Related]
13. A Novel Biomarker-Based Preoperative Prognostic Grading System for Predicting Survival After Surgery for Intrahepatic Cholangiocarcinoma.
Yoh T; Seo S; Hatano E; Taura K; Fuji H; Ikeno Y; Okuda Y; Yasuchika K; Kaido T; Okajima H; Uemoto S
Ann Surg Oncol; 2017 May; 24(5):1351-1357. PubMed ID: 28108828
[TBL] [Abstract][Full Text] [Related]
14. Clinical features of sarcomatoid change in patients with intrahepatic cholangiocarcinoma and prognosis after surgical liver resection: A Propensity Score Matching analysis.
Wang T; Kong J; Yang X; Shen S; Zhang M; Wang W
J Surg Oncol; 2020 Mar; 121(3):524-537. PubMed ID: 31867746
[TBL] [Abstract][Full Text] [Related]
15. An immunostaining panel of C-reactive protein, N-cadherin, and S100 calcium binding protein P is useful for intrahepatic cholangiocarcinoma subtyping.
Akita M; Sawada R; Komatsu M; Suleman N; Itoh T; Ajiki T; Heaton N; Fukumoto T; Zen Y
Hum Pathol; 2021 Mar; 109():45-52. PubMed ID: 33321161
[TBL] [Abstract][Full Text] [Related]
16. C-Reactive Protein (CRP) is a Promising Diagnostic Immunohistochemical Marker for Intrahepatic Cholangiocarcinoma and is Associated With Better Prognosis.
Yeh YC; Lei HJ; Chen MH; Ho HL; Chiu LY; Li CP; Wang YC
Am J Surg Pathol; 2017 Dec; 41(12):1630-1641. PubMed ID: 28945626
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Factors Associated with Preoperative Clinicophysiological Outcomes of Distal Cholangiocarcinoma.
Suzuki S; Kajiyama H; Shimoda M; Shimazaki J; Koike N; Harada N
Dig Surg; 2017; 34(6):476-482. PubMed ID: 28166534
[TBL] [Abstract][Full Text] [Related]
18. Negative impact of preoperative platelet-lymphocyte ratio on outcome after hepatic resection for intrahepatic cholangiocarcinoma.
Chen Q; Dai Z; Yin D; Yang LX; Wang Z; Xiao YS; Fan J; Zhou J
Medicine (Baltimore); 2015 Apr; 94(13):e574. PubMed ID: 25837750
[TBL] [Abstract][Full Text] [Related]
19. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
[No Abstract] [Full Text] [Related]
20. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma.
Su CH; Tsay SH; Wu CC; Shyr YM; King KL; Lee CH; Lui WY; Liu TJ; P'eng FK
Ann Surg; 1996 Apr; 223(4):384-94. PubMed ID: 8633917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
